Literature DB >> 28844943

The Unknown Aspect of BAFF: Inducing IL-35 Production by a CD5+CD1dhiFcγRIIbhi Regulatory B-Cell Subset in Lupus.

Yamin Zhang1, Jun Li2, Nuoya Zhou1, Yi Zhang1, Min Wu3, Jian Xu4, Chen Shen1, Xiangjie An1, Guanxin Shen3, Ming Yang5, Chun Zhang6, Juan Tao7.   

Abstract

IL-35 is a critical immunosuppressive cytokine that plays an important role in various autoimmune diseases. The purpose of this study was to determine whether BAFF, a key pathogenic factor in systemic lupus erythematosus, also a dichotomous regulator for B-cell immune responses, has an effect on IL-35-producing regulatory B cells and their underlying mechanisms in lupus. We found that exogenous BAFF could induce IL-35 production by splenic B cells from MRL-Faslpr/lpr mice. BAFF-induced IL-35-producing B cells were mainly from the marginal zone B-cell subset and exhibited a CD5+CD1dhiFcγRIIbhi phenotype. These IL-35-producing regulatory B-cell subsets exhibited regulatory effects on both CD4+CD25- T cells and CD4+CD25+ regulatory T cells. We further identified that BAFF-TACI interaction could induce the production of IL-35 through the classical NF-κB1 pathway. In vivo study also showed that BAFF could facilitate IL-35 secretion in marginal zone B cells, whereas anti-BAFF treatment could decrease the frequency of IL-35-producing CD5+CD1dhiFcγRIIbhi B cells in MRL-Faslpr/lpr mice. We showed that BAFF could induce IL-35 production by a unique CD5+CD1dhiFcγRIIbhi regulatory B-cell subset mainly through TACI activation in lupus, providing an advanced understanding of the regulatory effect of BAFF in autoimmune diseases.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28844943     DOI: 10.1016/j.jid.2017.07.843

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

1.  Regulatory B Cells in Type 1 Diabetes.

Authors:  Joanne Boldison; Larissa Camargo Da Rosa; F Susan Wong
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Epigenetic regulation of B cells and its role in autoimmune pathogenesis.

Authors:  Fan Xiao; Ke Rui; Xiaofei Shi; Haijing Wu; Xiaoyan Cai; Kathy O Lui; Qianjin Lu; Esteban Ballestar; Jie Tian; Hejian Zou; Liwei Lu
Journal:  Cell Mol Immunol       Date:  2022-10-12       Impact factor: 22.096

Review 3.  Immunosuppressive Mechanisms of Regulatory B Cells.

Authors:  Diego Catalán; Miguel Andrés Mansilla; Ashley Ferrier; Lilian Soto; Kristine Oleinika; Juan Carlos Aguillón; Octavio Aravena
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 7.561

Review 4.  IL-35: a new immunomodulator in autoimmune rheumatic diseases.

Authors:  Lazaros I Sakkas; Athanasios Mavropoulos; Carlo Perricone; Dimitrios P Bogdanos
Journal:  Immunol Res       Date:  2018-06       Impact factor: 4.505

Review 5.  Regulatory B and T lymphocytes in multiple sclerosis: friends or foes?

Authors:  Georgios K Vasileiadis; Efthymios Dardiotis; Athanasios Mavropoulos; Zisis Tsouris; Vana Tsimourtou; Dimitrios P Bogdanos; Lazaros I Sakkas; Georgios M Hadjigeorgiou
Journal:  Auto Immun Highlights       Date:  2018-11-10

Review 6.  Advances of Regulatory B Cells in Autoimmune Diseases.

Authors:  Qiugang Zhu; Ke Rui; Shengjun Wang; Jie Tian
Journal:  Front Immunol       Date:  2021-04-15       Impact factor: 7.561

7.  Deconvolution of B cell receptor repertoire in multiple sclerosis patients revealed a delay in tBreg maturation.

Authors:  Yakov A Lomakin; Ivan V Zvyagin; Leyla A Ovchinnikova; Marsel R Kabilov; Dmitriy B Staroverov; Artem Mikelov; Alexey E Tupikin; Maria Y Zakharova; Nadezda A Bykova; Vera S Mukhina; Alexander V Favorov; Maria Ivanova; Taras Simaniv; Yury P Rubtsov; Dmitriy M Chudakov; Maria N Zakharova; Sergey N Illarioshkin; Alexey A Belogurov; Alexander G Gabibov
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

Review 8.  Marginal Zone B-Cell Populations and Their Regulatory Potential in the Context of HIV and Other Chronic Inflammatory Conditions.

Authors:  Kim Doyon-Laliberté; Matheus Aranguren; Johanne Poudrier; Michel Roger
Journal:  Int J Mol Sci       Date:  2022-03-21       Impact factor: 5.923

9.  Serum markers of B-cell activation in pregnant women with atopic asthma.

Authors:  Catarina Martins; Jorge Lima; Geraldine Cambridge; Miguel Ângelo-Dias; Maria Leandro; Luís Miguel Borrego
Journal:  Am J Reprod Immunol       Date:  2021-03-19       Impact factor: 3.886

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.